AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 11th, 2021 • Nabriva Therapeutics PLC • Pharmaceutical preparations • California
THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”), is made as of March 10, 2021 by and between Nabriva Therapeutics US, Inc. (the “Company”), and Theodore R. Schroeder (the “Executive”) (together, the “Parties”).
NABRIVA THERAPEUTICS US, INC. CONSULTING AGREEMENTConsulting Agreement • March 11th, 2021 • Nabriva Therapeutics PLC • Pharmaceutical preparations • Pennsylvania
This Consulting Agreement (“Agreement”) is dated as of March 9, 2021 and effective as of March 15, 2021 (the “Effective Date”) by and between Nabriva Therapeutics US, Inc., a Delaware corporation, with a business address of 1000 Continental Drive, Suite 600, King of Prussia, Pennsylvania 19406 (“Company”), and Sender Consulting LLC having an address at [**] (“Consultant”).
AMENDMENT TO THE LICENSE AGREEMENTLicense Agreement • March 11th, 2021 • Nabriva Therapeutics PLC • Pharmaceutical preparations
This Amendment to the License Agreement (this Amendment) is made and entered into effective as of October 29, 2020 (the Effective Date)
